Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-26 @ 1:48 AM
Study NCT ID:
NCT04059094
Status:
TERMINATED
Last Update Posted:
2021-06-04
First Post:
2019-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-15
First Submit QC Date:
None
Study First Post Date:
2019-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-15
Results First Submit QC Date:
None
Results First Post Date:
2021-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-11
Last Update Post Date:
2021-06-04
Last Update Post Date Type:
ACTUAL